SARS-CoV-2: News
New coronavirus strain has potential to trigger next pandemic: Study
A new study has raised concerns over a subgroup of bat coronaviruses, called HKU5, which could pose a pandemic risk.
This single vaccine protects you against COVID-19, flu, common cold
A team of scientists at Scripps Research has developed a groundbreaking universal vaccine.
Scientists discover why COVID vaccine causes chronic illness in some
A team of researchers from Yale University has found clues regarding why a small percentage of people experience chronic symptoms after COVID vaccination, which they have dubbed "post-vaccination syndrome (PVS)."
US documents highlight concerns in Wuhan lab in post-COVID scrutiny
Recently disclosed documents have raised concerns over safety and transparency in viral research at China's Wuhan Institute of Virology (WIV).
In a first, scientists create mice with human immune system
Scientists at The University of Texas Health Science Center at San Antonio have made a significant breakthrough by developing the first mouse model with a fully operational human immune system.
AI could predict and warn before next pandemic breaks out
Scientists have developed an Early Warning Anomaly Detection (EWAD) system that accurately predicts new variants of concern (VOCs) in future pandemics.
Chinese province deletes COVID-19 mortality data: Report
China's Zhejiang province has deleted mortality data that showed the impact of the relaxation of COVID-19 restrictions last year on its death toll, reported the Financial Times.
India reports highest daily COVID-19 cases in 2023: Check tally
For the first time in 2023, India reported more than 1,100 COVID-19 daily cases, triggering fresh concerns among people about the recent outspread of the novel virus.
COVID-19 subvariant XBB 1.16 cases rise in India; guidelines revised
The Centre has issued revised guidelines amid the continuous daily COVID-19 case spike in the country.
COVID-19 origin from raccoon dogs in China, not bats: Study
Ever since the spread of COVID-19, the possible sources of its origin have puzzled scientists.
#NewsBytesExplainer: The risks of developing long COVID symptoms
The impact of COVID-19 is anticipated to last for a very long time among people who got the deadly illness during the pandemic.
Immune response induced by COVID-19 can seriously damage brain: Study
The immunological response induced by COVID-19 infection can damage blood vessels in the brain and cause short and long term neurological problems, a study by the National Institutes of Health (NIH) revealed.
COVID-19 survivors at risk of developing serious blood clots: Study
A new study has found people infected with SARS-CoV-2—the virus that causes COVID-19—are at a higher risk of developing serious blood clots for up to six months, even in the case of mild infections.
Coronavirus may remain active for longer than recommended quarantine: Study
Several people infected with SARS-CoV-2, the virus that causes COVID-19, may spread it for longer than the prescribed quarantine period, even if they don't show any symptoms throughout the infection's final stage, a study has claimed.
Mu, C.1.2 variants of SARS-CoV2 not found in India: INSACOG
India has so far not seen Mu and C.1.2, the two new variants of SARS-CoV2, and the Delta variant and its sub-lineages continue to be the main Variants of Concern in the country, INSACOG, the genome sequencing consortium, has said.
COVID-19 'not developed' as a biological weapon: US Intelligence Community
SARS-CoV-2 was "not developed" as a biological weapon, the US intelligence community has concluded in a report, with President Joe Biden reiterating the allegation that China continues to reject calls for transparency and withhold information about the origins of the virus.
COVID-19 most-transmissible two days before, three days after symptoms appear
People infected with the SARS-CoV-2 virus, which causes COVID-19, are most contagious two days before, and three days after they develop symptoms, according to a study conducted in China.
COVID-19 may become childhood disease in few years: Study
COVID-19 may behave like other common-cold coronaviruses in the next few years, affecting mostly young children who haven't yet been vaccinated or exposed to the virus, according to a modeling study published on Thursday.
Delta variant behind majority of 'breakthrough' infections: Study
The Delta variant of SARS-COV-2 was behind the majority of clinical cases of breakthrough infection of COVID-19 but only 9.8% of cases required hospitalization and fatality was observed in only 0.4% of the cases, according to a new study by the Indian Council of Medical Research (ICMR).
Synthetic SARS-CoV-2 could be used as COVID-19 antiviral therapy: Study
Researchers have designed a synthetic defective SARS-CoV-2 that can interfere with the growth of the real virus, potentially leading to the extinction of both the COVID-19 causing pathogen and the artificial one.
Nasal COVID-19 vaccine prevents disease, transmission in animals: Study
A new single-dose, intranasal COVID-19 vaccine fully protects mice against lethal infection, and also blocks transmission of the SARS-CoV-2 virus in ferrets, a study has shown.
COVID-19 likely of natural origin, not leaked from lab: Study
The SARS-CoV-2 virus, which causes COVID-19, most likely spread from an animal source to humans and did not leak from a laboratory in Wuhan, China, according to a review of existing scientific evidence by a global team of scientists.
New drug target to treat coronavirus, fight future pandemic found
Scientists have identified a novel target for a drug that can treat SARS-CoV-2, which causes COVID-19, and also help tackle a future coronavirus pandemic.
Scientists identify new post-infection treatment for COVID-19
Scientists have identified a post-infection treatment for SARS-CoV-2, the virus that causes COVID-19, and successfully demonstrated its efficacy in stopping viral reproduction in mice.
Two COVID-19 vaccines for young children show promise in trials
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists said.
Prior infection cuts COVID-19 risk for upto 10 months: Lancet
The risk of being infected with SARS-CoV-2, the virus that causes COVID-19, is substantially reduced for up to 10 months following the first infection with the virus, according to a study.
Dr. Fauci's leaked 2020 emails reveal knowledge of lab-leak theory
Not long after Dr. Anthony Fauci changed his tune on the possibility that the COVID-19 could be man-made, more skeletons tumble out of the US medical advisor's closet.
NewsBytes Explainer: Did COVID-19 leak from Wuhan lab?
What was once considered heresy and "debunked" mercilessly returns with a vengeance. After shocking admission by Dr. Anthony Fauci that COVID-19 could have originated from Chinese virology labs in Wuhan, Facebook says that it won't censor discussions on the SARS-CoV-2 virus being man-made.
COVID-19 could become like common cold in future: Study
The novel coronavirus responsible for COVID-19 could cause no more than common cold-like coughs and sniffles within the next decade, according to a study.
COVID-19: UK variant dominates north India, double mutant in west
The UK strain of coronavirus is currently dominating parts of north India while double mutant could be found mostly in Maharashtra, Karnataka, and Gujarat, Sujeet Singh, Director of National Centre for Disease Control (NCDC), has said.
Is transmission of COVID-19 airborne? All you need to know
Since the COVID-19 pandemic began, several experts have attempted to shift focus toward the airborne transmission of the virus, which is often overlooked, even in protocols designed to keep the virus at bay.
COVAXIN neutralizes double mutant strain: ICMR
Indigenously developed COVID-19 vaccine, COVAXIN, neutralizes multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
Wearing two fitted masks may double protection against COVID-19: Study
Wearing two tightly-fitted face masks can double the effectiveness of filtering out SARS-CoV-2-sized particles, preventing them from reaching the wearer's nose and mouth and causing COVID-19, according to a study.
These tools can prevent COVID-19 surges without restricting movement
A combination of robust vaccination programs and strict physical distancing rules may be enough to prevent recurring peaks of COVID-19 without greatly restricting the mobility of people, according to a modeling study.
Climate change may have influenced the emergence of coronavirus: Study
Climate change may have influenced the outbreaks of the novel coronavirus as well as the year 2002-03 SARS pandemic virus, suggests a new study published in the journal Science of The Total Environment.
COVID-19: Scientists develop new tool to decontaminate viruses in aerosols
Scientists have engineered a new tool that exposes aerosolized virus particles to microwaves in a controlled manner, an advancement that may lead to the development of novel methods to reduce the spread of the coronavirus.
7.4 crore Indians exposed to coronavirus till August: ICMR serosurvey
As many as 7.4 crore people in India, or about 7% of the total population, were exposed to the novel coronavirus till August this year, revealed the second nationwide serological survey by the Indian Council of Medical Research (ICMR).
Coronavirus: US scientists identify possible treatment for SARS-CoV-2
A study in the United States has found a potential therapeutic treatment for COVID-19, the viral disease that has afflicted over 18 million worldwide.
In a first, Indian scientists capture image of novel coronavirus
Scientists in Pune have managed to capture the image of the novel coronavirus responsible for the current COVID-19 outbreak.
Coronavirus hoax viral on WhatsApp; claims garlic can cure disease
Adding to the growing threat of a coronavirus outbreak, a false cure is being circulated on the messaging app WhatsApp.